A road map to success in med tech at Genesis 2009

MEDICAL TECHNOLOGY @ GENESIS CONFERENCE 2009

WEDNESDAY 10TH – THURSDAY 11TH DECEMBER

QE2 CONFERENCE CENTRE, WESTMINSTER, LONDON, UK

Delegate fees from £70 + VAT available



Delivered as an integral part of well established annual Genesis Conference (www.genesisconference.com), LBN, ERBI and SEHTA have collaborated to produce two days of presentations, debates, exhibition and online networking for the medical technology sector alongside their bio-pharma partners.

Thursday 10th December

08.30 Conference Opens

09.00 – 11.00 Genesis Plenary Session

10.50 – 11.30 Tea/Coffee, networking and exhibitor visits

11.30 – 13.00 Genesis Sessions: “Bioengineering in Medicine” & “Imaging in Drug Discovery”

13.00 – 14.15 Lunch, networking and exhibitor visits

14.15 – 15.45 Genesis Sessions: “Nurturing Innovative Medical Technology” & Current pe-clinical strategies”

15.45 – 16.30 Tea/Coffee, networking and exhibitor visits

16.30 – 18.00 Genesis Conference sessions: Latest approaches to clinical trial design” & “Next wave technologies in drug discovery”

18.00 – Drinks reception followed by the UKTI Genesis Awards Dinner

Friday 11th December 2009

08.50Welcome from the Chair, David Parry, CEO SEHTA

09.00 – 10.00 Session 1 – Setting off

09.00 The structure of the medical technology sector in the UK

Barnaby Perks, ERBI

09.20 Evaluating the market potential of your product

MATCH Speaker tbc

09.40 Developing the value proposition for investors

Stuart Hendry, Sphere Medical

10.00 – 10.30 – Coffee

10.30– 11.30 Session 2 – Are we there yet?

10.30 Comparing the FDA and EMEA approaches to approval for biomarkers

Patricia Hurley, Head of Biomarkers Division, ERA Consulting

10.50 Undertaking med tech clinical trials in the NHS

Prof. Gordon Ferns, Dean of Medicine, University of Surrey

11.10 Preparing to market your product

Bill Dolphin, Avita Medical

11.30 – 12.15 – Coffee and refreshment

12.00 – 13.15 – Session 3 – We've arrived!

12.00 Building revenues through entering the US market

Ted Agne, Communications Strategy Group

12.20 Keynote Debate:

The OLS Blueprint has the NHS as an Innovation Champion, but how can you get your innovative med tech product adopted by the NHS?

Chair: Bill Dawson

Panellists:

Prof Gordon Ferns, University of Surrey

Mark McIntyre, Boston Scientific

Others to be confirmed

13.15 Conference close